EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes

Tong Liu iD, Yanjun Wang iD, Bing Qian iD, Pan Li iD

BioMed Research International · 23.05.2024 · 2024 · 1-13

DOI: 10.1155/2024/6640796 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioMed Research International, erschienen am 23.05.2024. Verfasst von Tong Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department Honghui Hospital Xi'an Jiaotong University School of Medicine, Xi'an, China. Hauptthemen laut MEDLINE: Osteoporosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes has a significant global prevalence. Chronic hyperglycemia affects multiple organs and tissues, including bones. A large number of diabetic patients develop osteoporosis; however, the precise relationship between diabetes and osteoporosis remains incompletely elucidated. The activation of the AGE-RAGE signaling pathway hinders the differentiation of osteoblasts and weakens the process of bone formation due to the presence of advanced glycation end products. High glucose environment can induce ferroptosis of osteoblasts and then develop osteoporosis. Hyperglycemia also suppresses the secretion of sex hormones, and the reduction of testosterone is difficult to effectively maintain bone mineral density. As diabetes therapy, thiazolidinediones control blood glucose by activating PPAR- γ . Activated PPAR- γ can promote osteoclast differentiation and regulate osteoblast function, triggering osteoporosis. The effects of metformin and insulin on bone are currently controversial. Currently, there are no appropriate tools available for assessing the risk of fractures in diabetic patients, despite the fact that the occurrence of osteoporotic fractures is considerably greater in diabetic individuals compared to those without diabetes. Further improving the inclusion criteria of FRAX risk factors and clarifying the early occurrence of osteoporosis sites unique to diabetic patients may be an effective way to diagnose and treat diabetic osteoporosis and reduce the risk of fracture occurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisHumansRisk FactorsOsteoporotic FracturesFractures, BoneMetabolic Networks and PathwaysDiabetes MellitusBone DensityOsteoblastsSignal Transduction

Autor:innen und Institutionen

  • Emergency Department Honghui Hospital Xi'an Jiaotong University School of Medicine, Xi'an, China.

ORCID-Profile: Tong Liu, Yanjun Wang, Bing Qian, Pan Li

Zitieren

APA

Liu, T., Wang, Y., Qian, B., & Li, P. (2024). Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes. BioMed Research International, 2024, 1-13. https://doi.org/10.1155/2024/6640796

Vancouver

Liu T, Wang Y, Qian B, Li P. Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes. BioMed Research International. 2024;2024:1-13. doi:10.1155/2024/6640796

BibTeX
@article{Liu2024,
  author = {Liu, Tong and Wang, Yanjun and Qian, Bing and Li, Pan},
  title = {Potential Metabolic Pathways Involved in Osteoporosis and Evaluation of Fracture Risk in Individuals with Diabetes},
  journal = {BioMed Research International},
  year = {2024},
  volume = {2024},
  pages = {1--13},
  doi = {10.1155/2024/6640796}
}
Kostenlos starten →